investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
Jordan Meier
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Masoud Vedadi
University of Toronto
Toronto, Canada
Jordan Meier
National Cancer Institute (NIH)
Rockville, United States
Related projects
Huiyan Zeng
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis
All cancers but non-melanoma skin cancer
Antonio Di Cristofano
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
All cancers but non-melanoma skin cancer
Gajanana Datta
Improved metabolic imaging using hyperpolarized 13C MR substrates
All cancers but non-melanoma skin cancer
Leonard Neckers
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
All cancers but non-melanoma skin cancer
Christopher Westlake
Regulation of Ciliogenesis and Ciliary-related signaling
All cancers but non-melanoma skin cancer
Konstantin V Sokolov
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
All cancers but non-melanoma skin cancer
William C Hahn
Systematic identification of oncogenic KRAS synthetic lethal interactions
All cancers but non-melanoma skin cancer
William Figg
Development of Angiogenesis Inhibitors
All cancers but non-melanoma skin cancer
Stefan Taubert
CRC Tier 2 - Studying Mediator Components
All cancers but non-melanoma skin cancer